Why the study?
Does a single dose of quinidine alter serum digoxin levels in patients on maintenance digoxin therapy?
Does a single dose of quinidine alter serum digoxin levels in patients on maintenance digoxin therapy?
Co-administration of a single dose of quinidine with oral digoxin significantly increases peak serum digoxin levels, highlighting a clinically important pharmacokinetic drug-drug interaction.
Alerts to potential digoxin toxicity risk with quinidine; leaves open confirmation in larger maintenance-therapy trials.
To determine whether a single dose of quinidine sulfate might alter serum digoxin levels, patients receiving maintenance digoxin therapy who required quinidine had their serum digoxin levels measured after oral administration of digoxin, quinidine, or both. In group 1, digoxin and quinidine were administered orally together; in group 2, digoxin was administered orally alone; and in group 3, quinidine was administered orally, 24 hours after the last dose of digoxin. In group 1, serum digoxin level increased by 2.0+/-0.4 ng/mL (from 1.0+/-0.1 ng/mL), but in group 2, serum digoxin level increased by only 1.0+/-0.1 ng/mL (from 1.0+/-0.1 ng/mL). Group 3 showed no change in serum digoxin concentration. Time of maximum digoxin concentration also occurred earlier when digoxin and quinidine were administered together. Thus, a single dose of quinidine will increase the peak digoxin level when administered together with oral digoxin.
No takes yet. Share an insight, caveat, or question.
Tsan-Shih Chen (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: